Pfizer, BioNTech collaborate on global COVID-19 vaccine development
Pfizer and BioNTech will jointly develop COVID-19 vaccine, initially in the US and Europe, and scale-up manufacturing capacity…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
13 Apr 20
Pfizer and BioNTech will jointly develop COVID-19 vaccine, initially in the US and Europe, and scale-up manufacturing capacity…
09 Apr 20
Novavax will incorporate its Matrix-M adjuvant with NVX-CoV2373 to enhance immune responses and stimulate increased levels of neutralising…
09 Mar 20
The company's internal discovery programme is focused on its patented transgenic mouse platform (Harbour Mice) for generating fully…
03 Mar 20
The acquisition of Forty Seven will strengthen Gilead’s immuno-oncology research and development portfolio with the addition of Forty…
02 Mar 20
Altimmune has designed the vaccine using its original technology and is accelerating the vaccine development toward animal testing…
26 Feb 20
The companies will work closely on the clinical development, manufacturing, and commercialization of antibodies developed by Vir Biotechnology
After decreasing each year between 2014 and 2017, the life expectancy rate in the US is thought to…
12 Feb 20
BARDA will finance the development of vaccine candidate, while Janssen will upscale the production and manufacture the vaccine…
The coronavirus was originally reported in Wuhan, China at the end of 2019, and the first cases of…
03 Feb 20
Under the terms of the agreement, GSK will offer its pandemic vaccine adjuvant technology to improve the development…